Abraxis and AstraZeneca are partnering to support disease state educational
programs that help address the unmet needs of health care professionals. We
also recognize the importance of upholding the integrity of medical education,
and hope that the following information will be a valuable resource to
individuals and organizations in the completion of successful grant
applications.
Educational Interest
Independent educational programs supported by Abraxis and AstraZeneca will be
consistent with one of the following areas of educational interest:
-
Breast cancer
-
Lung Cancer
-
Melanoma
-
Ovarian/Gynecologic Cancers
-
Prostate Cancer
-
Upper GI (pancreatic) Cancer
-
Head & Neck Cancer
-
General Oncology
-
Nanotechnology
Atlanta Braves
Detroit Tigers
Sarah Vowell
Educational Intent
When evaluating grant applications for educational programs, the Review Team
will look for those programs whose content aligns with the following statements
of educational intent:
-
The program supports an educational need by providing valuable disease state
information to enhance patient care
-
The program will help develop or increase knowledge and skills that healthcare
professionals use to provide services for the public and patients
-
The program will help develop or increase knowledge of novel and emerging
therapies based on a documented unmet need
-
The program will include global and US research perspectives, including
molecular correlations
-
The program incorporates EBM (Evidence Based Medicine) related to core
objectives, as well as methodology itself
-
The program will assist physicians in carrying out their diagnosis and
treatment strategies more effectively and efficiently
-
The program will help develop or increase patient knowledge of disease state
and treatment options